![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 39, 30701-30706, September 29, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the P2Y ATP receptors are widely expressed in
mammalian tissues and regulate a broad range of activities. Multiple
subtypes of P2Y receptors have been identified and are distinguished
both on a molecular basis and by pharmacologic substrate preference. Functional evidence suggests that hepatocytes from the little skate
Raja erinacea express a primitive P2Y ATP receptor lacking pharmacologic selectivity, so we cloned and characterized this receptor. Skate hepatocyte cDNA was amplified with degenerate oligonucleotide probes designed to identify known P2Y subtypes. A
single polymerase chain reaction product was found and used to
screen a skate liver cDNA library. A 2314-base pair cDNA clone was generated that contained a 1074-base pair open reading frame encoding a 357-amino acid gene product with 61-64% similarity to
P2Y1 receptors and 21-37% similarity to other P2Y
receptor subtypes. Pharmacology of the putative P2Y receptor was
examined using the Xenopus oocyte expression system and
revealed activation by a range of nucleotides. The receptor was
expressed widely in skate tissue and was expressed to a similar extent
in other primitive organisms. Phylogenetic analysis suggested that this
receptor is closely related to a common ancestor of the P2Y subtypes
found in mammals, avians, and amphibians. Thus, the skate liver P2Y receptor functions as a primitive P2Y ATP receptor with broad pharmacologic selectivity and is related to the evolutionary forerunner of P2Y1 receptors of higher organisms. This novel receptor
should provide an effective comparative model for P2Y receptor
pharmacology and may improve our understanding of nucleotide
specificity among the family of P2Y ATP receptors.
A Primitive ATP Receptor from the Little Skate Raja
erinacea*
§¶,
§,
,
,
,
,
§, and
§
Department of Medicine and Liver Study Unit,
Yale University School of Medicine, New Haven, Connecticut 06520, the § Mount Desert Island Biological Laboratories, Salisbury
Cove, Maine 04672, and the
Department of Environmental
Medicine, University of Rochester School of Medicine,
Rochester, New York 14642
*
This work was supported by a Basic Science Award from the
Glaxo Institute of Digestive Health (to J. A. D.), a Student
Research Award from the American Digestive Health Foundation (to
A. F. O.), National Institutes of Health Grants DK45710,
DK34989, DK25636, and ES03828, and grants from the American Heart
Association, the Cystic Fibrosis Foundation, and the Salisbury Cove
Research Fund.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Lee, S. C. Wolff, R. A. Nicholas, and S. M. O'Grady P2Y Receptors Modulate Ion Channel Function through Interactions Involving The C-Terminal Domain Mol. Pharmacol., April 1, 2003; 63(4): 878 - 885. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |